Our results are similar to those obtained by Rocha et al. [75], who observed that the downregulation of NRF2 in serum-cultivated GBM cells increased their sensitivity to TMZ by reducing proliferation, increasing sub-G1 population, and increasing H2AX-positive cells. The gene discussed is H2AX; the disease is glioblastoma.